{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:19:47Z","timestamp":1789168787217,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.urolonc.2025.08.032","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T19:24:49Z","timestamp":1758828289000},"page":"696.e1-696.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utilization of intravesical chemotherapy following TURBT: A pre-implementation analysis of American College of Surgeon Commission on Cancer GU quality measures"],"prefix":"10.1016","volume":"43","author":[{"given":"Omri","family":"Nativ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-5704","authenticated-orcid":false,"given":"Sabika","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanoj","family":"Punnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gonzalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipen J.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Scarpato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohummad Minhaj","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad R.","family":"Ritch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2025.08.032_bib0001","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0002","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1100\/tsw.2006.404","article-title":"Natural history, recurrence, and progression in superficial bladder cancer","volume":"6","author":"Sylvester","year":"2006","journal-title":"Scient World J"},{"issue":"6 Pt 1","key":"10.1016\/j.urolonc.2025.08.032_bib0003","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","article-title":"A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","volume":"171","author":"Sylvester","year":"2004","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.08.032_bib0004","doi-asserted-by":"crossref","first-page":"477","DOI":"10.6004\/jnccn.2013.0060","article-title":"Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"11","author":"Abern","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.urolonc.2025.08.032_bib0005","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eururo.2013.06.009","article-title":"Immediate post-transurethral resection of bladder tumor intravesical chemotherapy prevents non-muscle-invasive bladder cancer recurrences: an updated meta-analysis on 2548 patients and quality-of-evidence review","volume":"64","author":"Perlis","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0006","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. ISBN 978-94-92671-23-3."},{"key":"10.1016\/j.urolonc.2025.08.032_bib0007","series-title":"Bladder cancer diagnosis and management","year":"2015"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0008","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0009","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00345-013-1142-z","article-title":"The use of immediate postoperative instillations of intravesical chemotherapy after TURBT of NMIBC among European countries","volume":"32","author":"Palou-Redorta","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0010","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/bju.12235","article-title":"Snapshot of transurethral resection of bladder tumours in the United Kingdom Audit (STUKA)","volume":"112","author":"Gan","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0011","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1002\/cncr.24311","article-title":"Treatment of non-muscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors","volume":"115","author":"Madeb","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0012","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.urology.2018.10.016","article-title":"Perioperative intravesical chemotherapy for patients with non-muscle invasive bladder cancer: understanding the extent of and sources of variation in guideline-recommended use","volume":"124","author":"Check","year":"2019","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.urolonc.2025.08.032_bib0013","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.purol.2009.06.009","volume":"19","author":"Descazeaud","year":"2009","journal-title":"Prog Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.032_bib0014","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.purol.2019.11.003","article-title":"Factors affecting guideline adherence in the initial treatment of non-muscle invasive bladder cancer: Retrospective study in a French peripheral hospital","volume":"30","author":"Jeglinschi","year":"2020","journal-title":"Prog Urol"},{"issue":"suppl 7","key":"10.1016\/j.urolonc.2025.08.032_bib0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/jco.2011.29.7_suppl.240","article-title":"Multiinstitutional quality-of-care initiative for nonmetastatic, muscle-invasive, transitional cell carcinoma of the bladder: phase I","volume":"29","author":"Feifer","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0016","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.juro.2010.09.015","article-title":"Treatment of muscle invasive bladder cancer: evidence from the National Cancer Database, 2003 to 2007","volume":"185","author":"Fedeli","year":"2011","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.08.032_bib0017","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.urolonc.2007.04.005","article-title":"Effect of advanced age on the development of complications from intravesical bacillus Calmette-Gu\u00e9rin therapy","volume":"26","author":"Heiner","year":"2008","journal-title":"Urol Oncol"},{"issue":"31","key":"10.1016\/j.urolonc.2025.08.032_bib0018","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016223","article-title":"The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer","volume":"98","author":"Cal\u00f2","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.urolonc.2025.08.032_bib0019","doi-asserted-by":"crossref","first-page":"431.e7","DOI":"10.1016\/j.urolonc.2023.05.019","article-title":"Underutilization of intravesical chemotherapy and immunotherapy for high grade non-muscle invasive bladder cancer in California between 2006-2018: effect of race, age and socioeconomic status on treatment disparities","volume":"41","author":"Noel","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2020.00085","article-title":"The Multidisciplinary Team (MDT) approach and quality of care","volume":"10","author":"Taberna","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69","author":"Sylvester","year":"2016","journal-title":"Eur Urol"},{"issue":"18","key":"10.1016\/j.urolonc.2025.08.032_bib0022","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2018.4657","article-title":"Effect of intravesical instillation of gemcitabine vs saline immediately following resection of suspected low-grade non\u2013muscle-invasive bladder cancer on tumor recurrence: SWOG S0337 randomized clinical trial","volume":"319","author":"Messing","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2025.08.032_bib0023","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.juro.2017.10.049","article-title":"Financial toxicity among patients with bladder cancer: reasons for delay in care and effect on quality of life","volume":"199","author":"Casilla-Lennon","year":"2018","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:16:02Z","timestamp":1763680562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925003503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1078143925003503"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.08.032","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of intravesical chemotherapy following TURBT: A pre-implementation analysis of American College of Surgeon Commission on Cancer GU quality measures","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}